Ultrasonic coagulation timer

• US 4,014,650 A
• Filed: 04/25/1975
• Issued: 03/29/1977
• Est. Priority Date: 04/25/1975
• Status: Expired due to Term

• Current Assignee: Research Corporation
• Original Assignee: Research Corporation
• Inventors: Sigelmann, Rubens A.
• Primary Examiner(s): Queisser, Richard C.
• Assistant Examiner(s): Roskos, Joseph W.
• Application Number:
  US05/571,507
• Time in Patent Office: 704 Days
• Field of Search: 73/64.1, 73/53, 73/552, 73/61 R, 73/67.7, 73/67.8 R, 23/230 B, 23/253 R
• US Class Current: 436/108
• CPC Class Codes: G01N 29/032 by measuring attenuation of acoustic waves
• CPC Class Codes: G01N 33/4905 Determining clotting time of blood by chemical methods G01N33/86, C12Q1/56
• CPC Class Codes: Y10T 436/171538 Urea or blood urea nitrogen

Abstract

A system for measuring the coagulation time of plasma or whole blood. A solution containing the blood sample is irradiated with pulsed ultrasound, and the back-scattered ultrasound is continuously measured. A predetermined quantity of thrombin is then added to the solution, causing the amplitude of the backscattered ultrasound to fluctuate until coagulation occurs. The elapsed time between the addition of thrombin and the inception of coagulation is the coagulation time, and is an indication of the concentration of fibrinogen in the blood sample.

Claims

1. A method of measuring the coagulation time of a solution containing whole blood or blood plasma, comprising:

directing ultrasound toward said solution and receiving the scattered ultrasound;

mixing a predetermined quantity of thrombin with said solution;

examining the scattered ultrasound for an indication that said solution has coagulated; and

measuring the elapsed tine between the mixing of thrombin with said solution and the coagulation of said solution.

2. The method of claim 1 wherein coagulation is indicated by a decrease in amplitude of fluctuations in scattering intensity.

3. The method of claim 1 wherein the received scattered ultrasound is converted into an electrical scattering signal indicative of the scattering intensity, said scattering signal being filtered to attenuate frequency components above a predetermined value, thereby obtaining an average scattering intensity signal.

4. The method of claim 3 wherein said average scattering intensity signal is continuously recorded during the period subsequent to mixing thrombin with the solution and prior to coagulation and wherein the recorded signal is examined for determining the presence of pathological coagulation.

5. The method of claim 4 wherein said pathological coagulation is indicated by a relatively indistinct indication of coagulation.

6. The method of claim 3 wherein said average scattering intensity signal is periodically sampled and converted to a binary coded signal corresponding to the amplitude of said sample and wherein the binary signal for each sample is digitally recorded.

7. The method of claim 6, further including the steps of:

initiating the counting of periodically occurring pulses when said thrombin is mixed with said solution;

examining the least significant digit of said binary coded signal for a plurality of successive samples; and

terminating the counting of said periodically occurring pulses when all of said binary signals are a predetermined value.

8. The method of claim 1 wherein the step of directing ultrasound toward said solution comprises:

transmitting a plurality of periodically occurring ultrasound bursts having a width approximately equal to the transit time of said ultrasound through said sample; and

wherein said step or receiving the scattered ultrasound comprises;

converting said ultrasound to an electrical signal indicative thereof;

band pass filtering said electrical signal to attenuate all frequencies substantially different from the frequency of said ultrasound;

applying the band pass filtered signal to a range gate, said range gate conducting a signal therethrough only during the occurrence of a range gate pulse, said range gate pulse occurring after the transmission of each ultrasound burst with a delay substantially equal to the time required for receiving scattered energy from each transmitted ultrasound burst;

generating an output signal indicative of the intensity of said range gated signal; and

sensing coagulation of said solution by examining said output signal for a change in amplitude of a fluctuating component of said output signal.

9. A method of detecting the termination of a biochemical reaction, comprising:

irradiating an ultrasound, transparent sample holder with ultrasound, said sample holder holding a first chemical reactant;

measuring the intensity of ultrasound scattering from the contents of said sample holder;

adding a second chemical reactant to said sample holder; and

sensing the occurrence of a marked decrease in amplitude of fluctuations in intensity of said ultrasound scattering.

10. An apparatus for measuring the coagulation time of a sample containing whole blood or blood plasma, comprising:

an ultrasound-transmissive medium;

a sample holder contained within said medium for receiving said sample, said sample holder having an ultrasound transparent window;

an ultrasound transducer contained within said medium and adapted to direct ultrasound toward said sample holder and to receive ultrasound scattering therefrom;

means for generating an ultrasound signal and driving said transducer with said signal; and

means for receiving ultrasound scattering from the contents of said sample holder, said receiving means including means for measuring the intensity of said scattered ultrasound and for producing a signal indicative thereof.

11. The apparatus of claim 10 wherein said means for transmitting said ultrasound signal comprises:

a pulse generator for periodically generating a first pulse;

an ultrasound generator actuated in response to said first pulse whereby said ultrasound generator periodically generates an ultrasound burst; and

said means for receiving ultrasound scattering comprises;

a band pass filter for receiving a scattering signal from said transducer, said filter having a pass band centered at the ultrasound frequency whereby the signal-to-noise ratio of said scattering signal is improved; and

means for producing an intensity signal having an amplitude indicative of the peak amplitude of said filtered ultrasound scattering signal.

12. The apparatus of claim 11 wherein said pulse generator produces a second pulse delayed from said first pulse by an amount substantially equal to twice the transit time of said ultrasound from said transducer to said sample holder and wherein said band pass filtered signal is applied to a range gate system including means responsive to said second pulse for conducting said signal to said means for producing an intensity signal.

13. The apparatus of claim 12, further including a low-pass filter for attenuating the frequency components in said intensity signal substantially above the frequency of intensity fluctuations in said scattering.

14. The apparatus of claim 11, further including means for digitally recording said intensity signal:

a master clock;

an analog-to-digital converter for generating a binary coded signal corresponding to the amplitude of said intensity signal; and

a shift register responsive to said master clock for entering the output of said analog-to-digital converter into said shift register for each master clock pulse and for shifting previously centered binary coded signals one shift register stage for each master clock pulse.

15. The appartus of claim 14, further including means for digitally indicating the thrombin time for a sample, comprising:

a digital counter incremented by said master clock;

means for resetting said digital counter when thrombin is added to said sample;

means for examining a plurality of successive stages in said shift register containing the least significant digit of said binary coded signal; and

means for disabling said digital counter when said examining means detects that said successive stages have identical numbers stored therein.

16. A method of measuring the coagulation time of a solution containing whole blood or blood plasma, comprising:

directing ultrasound toward said solution such that said ultrasound interacts with said solution;

receiving said ultrasound after interaction with said solution;

mixing a predetermined quantity of thrombin with said solution;

examining the received signal for a decrease in amplitude of fluctuations of said received signal responsive to coagulation of said solution; and

measuring the elapsed time between the mixing of thrombin with said solution and the coagulation of said solution.

17. A method of detecting the termination of a biochemical reaction, comprising:

irradiating an ultrasound, transparent sample holder with ultrasound, said sample holder containing a first chemical reactant such that said ultrasound interacts with the contents of said sample holder;

adding a second chemical reactant to said sample holder;

receiving said ultrasound after interaction with the contents of said sample holder; and

sensing the termination of said biochemical reaction by examining the received ultrasound for a decrease in amplitude of fluctuations of said received ultrasound responsive to termination of said reaction.